149 related articles for article (PubMed ID: 34392797)
1.
Ahlström MG; Knudsen JD; Hertz FB
Infect Dis (Lond); 2022 Jan; 54(1):26-35. PubMed ID: 34392797
[TBL] [Abstract][Full Text] [Related]
2. Stenotrophomonas maltophilia bacteremia and pneumonia at a tertiary-care oncology center: a review of 16 years.
Velázquez-Acosta C; Zarco-Márquez S; Jiménez-Andrade MC; Volkow-Fernández P; Cornejo-Juárez P
Support Care Cancer; 2018 Jun; 26(6):1953-1960. PubMed ID: 29307014
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of treatment outcomes for Stenotrophomonas maltophilia bacteraemia.
Lakatos B; Jakopp B; Widmer A; Frei R; Pargger H; Elzi L; Battegay M
Infection; 2014 Jun; 42(3):553-8. PubMed ID: 24627266
[TBL] [Abstract][Full Text] [Related]
4. Stenotrophomonas maltophilia bacteremia in children: risk factors and mortality rate.
Alsuhaibani M; Aljarbou A; Althawadi S; Alsweed A; Al-Hajjar S
Antimicrob Resist Infect Control; 2021 Jan; 10(1):19. PubMed ID: 33482916
[TBL] [Abstract][Full Text] [Related]
5. Appropriate antibiotic therapy is a predictor of outcome in patients with Stenotrophomonas maltophilia blood stream infection in the intensive care unit.
Lai JJ; Siu LK; Chang FY; Lin JC; Yu CM; Wu RX; Wang CH
J Microbiol Immunol Infect; 2023 Jun; 56(3):624-633. PubMed ID: 36948945
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes of Stenotrophomonas maltophilia infection treated with trimethoprim/sulfamethoxazole, minocycline, or fluoroquinolone monotherapy.
Junco SJ; Bowman MC; Turner RB
Int J Antimicrob Agents; 2021 Aug; 58(2):106367. PubMed ID: 34058337
[TBL] [Abstract][Full Text] [Related]
7. Emerging importance of multidrug-resistant Stenotrophomonas maltophilia infections in neonatal intensive care unit in a tertiary center in Turkey.
Demirbuğa A; Akgün Karapınar DB; Yaşa B; Çoban A; Öngen B; Dede E; Mete Atasever N; Somer A; Hançerli Törün S
Pediatr Neonatol; 2024 Mar; 65(2):183-187. PubMed ID: 37919104
[TBL] [Abstract][Full Text] [Related]
8. Comparisons between patients with trimethoprim-sulfamethoxazole-susceptible and trimethoprim-sulfamethoxazole-resistant Stenotrophomonas maltophilia monomicrobial bacteremia: A 10-year retrospective study.
Wang CH; Lin JC; Lin HA; Chang FY; Wang NC; Chiu SK; Lin TY; Yang YS; Kan LP; Yang CH; Chan MC; Yeh KM
J Microbiol Immunol Infect; 2016 Jun; 49(3):378-86. PubMed ID: 25081988
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for mortality in patients with Stenotrophomonas maltophilia bacteremia and clinical impact of quinolone-resistant strains.
Kim EJ; Kim YC; Ahn JY; Jeong SJ; Ku NS; Choi JY; Yeom JS; Song YG
BMC Infect Dis; 2019 Aug; 19(1):754. PubMed ID: 31462215
[TBL] [Abstract][Full Text] [Related]
10. Stenotrophomonas maltophilia in Malaysia: molecular epidemiology and trimethoprim-sulfamethoxazole resistance.
Neela V; Rankouhi SZ; van Belkum A; Goering RV; Awang R
Int J Infect Dis; 2012 Aug; 16(8):e603-7. PubMed ID: 22698885
[TBL] [Abstract][Full Text] [Related]
11. Molecular epidemiology and risk factors of Stenotrophomonas maltophilia infections in a Chinese teaching hospital.
Duan Z; Qin J; Liu Y; Li C; Ying C
BMC Microbiol; 2020 Sep; 20(1):294. PubMed ID: 32993493
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of Stenotrophomonas maltophilia infection in children in Sichuan, China, from 2010 to 2017.
Wang L; Zhou W; Cao Y; Yang C; Liu H; Chen T; Chen L
Medicine (Baltimore); 2020 Feb; 99(8):e19250. PubMed ID: 32080131
[TBL] [Abstract][Full Text] [Related]
13. Real-world, multicentre evaluation of the incidence and risk factors for non-susceptible Stenotrophomonas maltophilia isolates.
Jones BM; Wagner JL; Chastain DB; Bookstaver PB; Stover K; Lin J; Matson H; White N; Motesh M; Bland CM
J Glob Antimicrob Resist; 2022 Mar; 28():282-287. PubMed ID: 35150899
[TBL] [Abstract][Full Text] [Related]
14. Emergence of concurrent levofloxacin- and trimethoprim/sulfamethoxazole-resistant Stenotrophomonas maltophilia: Risk factors and antimicrobial sensitivity pattern analysis from a single medical center in Taiwan.
Wu RX; Yu CM; Hsu ST; Wang CH
J Microbiol Immunol Infect; 2022 Feb; 55(1):107-113. PubMed ID: 33500210
[TBL] [Abstract][Full Text] [Related]
15. Molecular epidemiology and characteristics of 16 cases with Stenotrophomonas maltophilia bacteraemia in pediatric Intensive Care Units.
Motamedifar M; Heidari H; Yasemi M; Sedigh Ebrahim-Saraie H
Ann Ig; 2017; 29(4):264-272. PubMed ID: 28569336
[TBL] [Abstract][Full Text] [Related]
16. Infection and colonization by Stenotrophomonas maltophilia: antimicrobial susceptibility and clinical background of strains isolated at a tertiary care centre in Hungary.
Juhász E; Krizsán G; Lengyel G; Grósz G; Pongrácz J; Kristóf K
Ann Clin Microbiol Antimicrob; 2014 Dec; 13():333. PubMed ID: 25551459
[TBL] [Abstract][Full Text] [Related]
17. Bloodstream infections caused by Stenotrophomonas maltophilia: a seven-year review.
Garazi M; Singer C; Tai J; Ginocchio CC
J Hosp Infect; 2012 Jun; 81(2):114-8. PubMed ID: 22494851
[TBL] [Abstract][Full Text] [Related]
18. Stenotrophomonas maltophilia bacteraemia in Turkish children.
Güriz H; Ciftçi E; Ayberkin E; Aysev D; Ince E; Arsan S; Yavuz G; Doğru U
Ann Trop Paediatr; 2008 Jun; 28(2):129-36. PubMed ID: 18510823
[TBL] [Abstract][Full Text] [Related]
19. Bacteraemia due to Stenotrophomonas maltophilia: an analysis of 45 episodes.
Friedman ND; Korman TM; Fairley CK; Franklin JC; Spelman DW
J Infect; 2002 Jul; 45(1):47-53. PubMed ID: 12217732
[TBL] [Abstract][Full Text] [Related]
20. Treatment of recurrent Stenotrophomonas maltophilia ventilator-associated pneumonia with doxycycline and aerosolized colistin.
Wood GC; Underwood EL; Croce MA; Swanson JM; Fabian TC
Ann Pharmacother; 2010 Oct; 44(10):1665-8. PubMed ID: 20736426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
